Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Preferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bruker (BRKR) Operating Expenses (2016 - 2026)

Bruker filings provide 16 years of Operating Expenses readings, the most recent being $372.9 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 11.47% to $372.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 8.1% increase, with the full-year FY2025 number at $1.5 billion, up 8.1% from a year prior.
  • Operating Expenses hit $372.9 million in Q4 2025 for Bruker, down from $431.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $431.2 million in Q3 2025 to a low of $189.6 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $256.3 million (2023), compared with a mean of $282.6 million.
  • Biggest five-year swings in Operating Expenses: surged 39.12% in 2023 and later dropped 11.47% in 2025.
  • Bruker's Operating Expenses stood at $216.2 million in 2021, then grew by 8.65% to $234.9 million in 2022, then soared by 39.12% to $326.8 million in 2023, then grew by 28.89% to $421.2 million in 2024, then fell by 11.47% to $372.9 million in 2025.
  • The last three reported values for Operating Expenses were $372.9 million (Q4 2025), $431.2 million (Q3 2025), and $346.0 million (Q2 2025) per Business Quant data.